biotechnology

Antibody developability checks are moving into discovery instead of waiting for development

FairJourney Bio's Maria Gonzalez-Pajuelo says developability has become a much more important consideration during antibody discovery.

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego CRO designs preclinical oncology models to match specific therapies, including orthotopic brain tumors and post-treatment PDX…

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

BDO’s bioTRAK data shows CDMOs plan about 120 new bioreactors by 2030: 71% of added liters are large-scale stainless steel, but 61% of systems are single-use.

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are expanding their strategic partnership, which began in 2023, with a series of substantial investments aimed at bolstering U.S. pharmaceutical manufacturing. The collaboration, marked by a $750 million investment, focuses on increasing the production of Lilly’s KwikPen®, a

4basebio hpDNA in Genezen projects could cut AAV input DNA by 30%

Genezen will offer 4basebio’s cell-free hpDNA as starting material for viral vectors, a shift that could change how programs specify plasmids, timelines, and CO

Bristol Myers exits Cellares deal, putting standardized cell therapy capacity in doubt

Bristol Myers ended its deal with Cellares, a reminder that cell therapy supply plans still hinge on process fit, not just factory slots.

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences initiates what it calls the first Phase I trial of an AI-designed oral drug formulation, approved by the UK's MHRA.

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I study of an AI-designed oral formulation, cleared by the MHRA, marking a concrete shift from AI experimentation to clin

Harnessing The Power Of Algae

With the world’s population increasing, energy demands are growing every day. However, the energy solution of the future might not be what you would expect. Researchers at the University of Cambridge has designed algae-powered full cells that are more powerful and cost effective than methods of the past. In order to accomplish this, the…

3D-printed live bacteria creates world’s first “living tattoo”

Things are alive at MIT these days, even tattoos! Recently, it was a team over at the university that was experimenting with genetically modified bacteria cells that led them into creating a new technique of 3D printing regarding tattoo design. It was through this concept that something special occurred, a living tattoo that provided…